MetBil as a novel molecular regulator in ischemia‐induced cardiac fibrosis via METTL3‐mediated m6A modification
Y Zhuang, T Li, X Hu, Y Xie, X Pei, C Wang… - The FASEB …, 2023 - Wiley Online Library
Cardiac fibrosis is a common pathological manifestation in multiple cardiovascular diseases
and often results in myocardial stiffness and cardiac dysfunctions. LncRNA (long noncoding …
and often results in myocardial stiffness and cardiac dysfunctions. LncRNA (long noncoding …
MetBil as a novel molecular regulator in ischemia-induced cardiac fibrosis via METTL3-mediated m6A modification
Y Zhuang, T Li, X Hu, Y Xie, X Pei… - … publication of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Cardiac fibrosis is a common pathological manifestation in multiple cardiovascular diseases
and often results in myocardial stiffness and cardiac dysfunctions. LncRNA (long noncoding …
and often results in myocardial stiffness and cardiac dysfunctions. LncRNA (long noncoding …
MetBil as a novel molecular regulator in ischemia-induced cardiac fibrosis via METTL3-mediated m6A modification.
Y Zhuang, T Li, X Hu, Y Xie, X Pei, C Wang… - … : Official Publication of …, 2023 - europepmc.org
Cardiac fibrosis is a common pathological manifestation in multiple cardiovascular diseases
and often results in myocardial stiffness and cardiac dysfunctions. LncRNA (long noncoding …
and often results in myocardial stiffness and cardiac dysfunctions. LncRNA (long noncoding …